welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, and Marina Biotech, Inc., a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced that the companies have executed a term sheet under which Microlin intends to acquire Marina’s nucleic acid therapeutics assets.

expertly curated content related to this topic
-
Katherine Berry, MSKatherine Berry, MS, is a board certifie...
-
Mattel Children’s Hospital UCLAUCLA Pediatric Surgeons have extensive e...
-
Lisen Axell, MS, CGCGenetic Counselor Lisen Axell has ...
-
Danielle C. Bonadies, MSShe served as an Assistant Director, Yal...
-
darrell henry’s sufferfestThis page is dedicated to Darrell Henry,...
-
Colorectal Cancer GuidelinesThe American Society of Colon and Rectal...
-
Maria Blazo, MDSpecialization: Medical Genetics Educ...